AbbVie is undervalued with strong EPS growth, rising immunology revenue, and a 3.43% yield. Check out ABBV's robust pipeline ...

Compared with people born from 1941 through 1949, incidence rates of appendix cancer have more than tripled among people born ...

I prefer high-yield income stocks for steady cash flow and peace of mind, highlighting two undervalued, large-scale ...

For the first time in more than three decades, the province is raising out-of-pocket prescription costs for seniors and ...